Form 485BPOS Equitable Financial Life
As filed with the Securities and Exchange Commission on August 22, 2025
REGISTRATION NOS. 333-283592; 333-153809
INVESTMENT COMPANY ACT NO. 811-01705
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
(File No. 333-283592)
FORM N-4
REGISTRATION STATEMENT
UNDER
| THE SECURITIES ACT OF 1933 | ☒ | |||
| Post-Effective Amendment No. 2 | ☒ | |||
| AND | ||||
| (File Nos. 333-153809; 811-01705) | ||||
| REGISTRATION STATEMENT UNDER |
||||
| THE SECURITIES ACT OF 1933 | ☒ | |||
| Post-Effective Amendment No. 32 | ☒ | |||
| AND/OR | ||||
| REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 |
☒ | |||
| Amendment No. 468 | ☒ | |||
(Check appropriate box or boxes)
SEPARATE ACCOUNT A
(Exact Name of Registered Separate Account)
EQUITABLE FINANCIAL LIFE INSURANCE COMPANY
(Name of Insurance Company)
1345 Avenue of the Americas, New York, New York 10105
(Address of Insurance Company’s Principal Executive Offices)
Insurance Company’s Telephone Number, including Area Code: (212) 554-1234
ALFRED AYENSU-GHARTEY
VICE PRESIDENT AND ASSOCIATE GENERAL COUNSEL
Equitable Financial Life Insurance Company
1345 Avenue of the Americas, New York, New York 10105
(Names and Addresses of Agents for Service)
Approximate Date of Proposed Public Offering: Continuous
It is proposed that this filing will become effective (check appropriate box):
| ☒ | Immediately upon filing pursuant to paragraph (b) |
| ☐ | On (date) pursuant to paragraph (b) |
| ☐ | 60 days after filing pursuant to paragraph (a)(1) |
| ☐ | On (date) pursuant to paragraph (a)(1) of Rule 485 under the Securities Act of 1933 (“Securities Act”). |
If appropriate, check the following box:
| ☐ | This post-effective amendment designates a new effective date for a previously filed post-effective amendment. |
Check each box that appropriately characterizes the Registrant:
| ☐ | New Registrant (as applicable, a Registered Separate Account or Insurance Company that has not filed a Securities Act registration statement or amendment thereto within 3 years preceding this filing) |
| ☐ | Emerging Growth Company (as defined by Rule 12b-2 under the Securities Exchange Act of 1934 (“Exchange Act”)) |
| ☐ | If an Emerging Growth Company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act |
| ☒ | Insurance Company relying on Rule 12h-7 under the Exchange Act |
| ☐ | Smaller reporting company (as defined by Rule 12b-2 under the Exchange Act) |
EXPLANATORY NOTE
Post-Effective Amendment No. 2 to the Form N-4 Registration Statement No. 333-283592 and Post-Effective Amendment No. 32 (the “PEA”) to the Form N-4 Registration Statement No. 333-153809 (the “Registration Statement”) of Equitable Financial Life Insurance Company (“Equitable Financial”) and its Separate Account A is being filed for the purpose of including in the Registration Statement the additions/modifications reflected in the Supplement and Part C. Post-Effective Amendment No. 2 incorporates by reference the information contained in Parts A and B of Post-Effective Amendment No. 1, filed on April 22, 2025. Post-Effective Amendment No. 32 incorporates by reference the information contained in Parts A and B of Post-Effective Amendment No. 31 filed on April 22, 2025.
Equitable Financial Life Insurance Company
Equitable Financial Life Insurance Company of America
Supplement dated August 22, 2025 to the current variable annuity prospectuses for:
| | EQUI-VEST® (Series 201) |
| | EQUI-VEST® (Series 202) |
| | EQUI-VEST® Strategies (Series 901) |
This Supplement updates certain information in the Appendix listing available Portfolio Companies in the most recent prospectuses, initial summary prospectuses and updating summary prospectuses for variable annuity contracts and in any supplements to those prospectuses, initial summary prospectuses and updating summary prospectuses (collectively, the “Prospectuses” or “Prospectus”). Unless otherwise indicated, all other information included in your prospectus remains unchanged. You should read this Supplement in conjunction with the Prospectus and retain it for future reference. The terms we use in this Supplement have the same meaning as in the Prospectus. We will send you another copy of any prospectus or supplement without charge upon request. Please contact the customer service group referenced in the Prospectus.
The Portfolios discussed below may not be available in all contracts. Please refer to your Prospectuses for the current variable investment options and corresponding underlying Portfolios available to you under your contract.
The purpose of this Supplement is to provide you with information regarding certain Portfolio substitutions. As is applicable to your contract, please note the following:
(1) Substitution of Underlying Portfolio Shares.
Subject to all necessary regulatory and other approvals, effective on or about October 24, 2025 (the “Substitution Date”), pursuant to the terms of your variable annuity contract and consistent with the terms and conditions of the U.S. Securities and Exchange Commission’s statement on insurance product fund substitutions, shares of the Replacement Portfolios listed in the table below will be substituted for shares of the corresponding Removed Portfolios listed opposite their names at relative net asset value. Each of the Removed Portfolios currently serves as an underlying Portfolio for a variable investment option. At the time of the substitution, each impacted variable investment option will change its name to correspond to the Replacement Portfolio name. We will automatically direct any contributions, allocation elections, rebalancing or other transaction made using the old variable investment option name to the applicable new variable investment option name. Until each substitution occurs, the variable investment option that invests in the underlying portfolio being substituted will be available for investment. You may continue to transfer your account value among the investment options prior to the substitution, as usual, including choosing to transfer your account value in an impacted variable investment option to other investment options under your contract. Once each substitution occurs, the variable investment option that invests in the underlying portfolio that was substituted will no longer be available for investment and the remaining account value in the Removed Portfolio will be transferred to the Replacement Portfolio. You are permitted to make transfers out of each Removed Portfolio to one or more other Portfolios.
Note: We will not exercise any rights reserved by us under the contract to impose additional restrictions on transfers until at least 30 days after the Substitution Date, and any transfers out of a Replacement Portfolio during the 30-day period following the Substitution Date will not count against any limited number of transfers or a limited number of transfers permitted without a transfer charge, as applicable. Please contact the customer service center referenced in your Prospectus for more information about your variable investment options and for information on how to transfer your account value.
The Removed Portfolios (current underlying Portfolios) and corresponding Replacement Portfolios (new underlying Portfolios) are:
| Removed Portfolio |
Replacement Portfolio | |||
| EQ/AB Sustainable U.S. Thematic Portfolio (Class IB) |
will be substituted for: | EQ/ClearBridge Large Cap Growth ESG (Class IB) | ||
| Invesco V.I. High Yield Fund (Series II) |
will be substituted for: | 1290 VT High Yield Bond Portfolio (Class IB) | ||
| Invesco V.I. Main Street Mid Cap Fund (Series II) |
will be substituted for: | EQ/Mid Cap Index Portfolio (Class IB) | ||
| Invesco V.I. Small Cap Equity Fund (Series II) |
will be substituted for: | 1290 VT GAMCO Small Company Value Portfolio (Class IB) |
| EV-201, 202 and 901 | Catalog No. 800233 | |
| IF/New Biz-Mail | #42477 |
| Removed Portfolio | Replacement Portfolio | |||
|
MFS® Investors Trust Series (Service Class) |
will be substituted for: | EQ/Fidelity Institutional AM® Large Cap Portfolio (Class IB) | ||
| Principal VC Equity Income Account (Class 2) |
will be substituted for: | EQ/Equity 500 Index Portfolio (Class IB) |
For some period of time after each substitution occurs, you may still receive correspondence or documents using the corresponding substituted fund name.
Note: You will not bear any of the expenses related to the substitutions, and the substitution will have no tax consequences for you.
(2) New Variable Investment Options
Subject to all necessary regulatory and other approvals, effective on or about October 24, 2025, pursuant to the terms of your variable annuity contract, and consistent with the terms and conditions of the U.S. Securities and Exchange Commission’s statement on insurance product fund substitutions, the following variable investment options and corresponding underlying fund portfolios will be available in the corresponding products:
| Variable Investment Option & Underlying Fund Portfolio |
Product(s) | |||
| EQ/ClearBridge Large Cap Growth ESG (Class IB) |
will be added to: | EQUI-VEST® (Series 201), EQUI-VEST® (Series 202) and EQUI-VEST® Strategies (Series 901) |
Therefore, the following information has been added to the “Investment options available under the contract” in the Prospectus:
Affiliated Portfolio Companies:
| TYPE | Portfolio Company — Investment Adviser; Sub-Adviser(s), as applicable | Current Expenses |
Average Annual Total Returns (as of 12/31/2024) | |||||||
| 1 year | 5 year | 10 year | ||||||||
| Equity | EQ/ClearBridge Large Cap Growth ESG — EIMG; ClearBridge Investments, LLC | 1.00%^ | 26.79% | 14.86% | 12.93% | |||||
| ^ | This Portfolio’s annual expenses reflect temporary fee reductions. |
Certain Removed Portfolios (and therefore the corresponding Replacement Portfolios) may not be available under your contract. See your Prospectus for more information.
2
PART C
OTHER INFORMATION
ITEM 27. EXHIBITS
| (a) | Board of Directors Resolutions. |
| (a) |
| (b) |
| (b) | Custodial Agreements. Not applicable. |
| (c) | Underwriting Contracts. |
| (a) |
| (b) |
| (c) |
| (d) |
C-1
| (d)(i) |
| (d)(ii) |
| (d)(iii) |
| (d)(iv) |
| (d)(v) |
| (d)(vi) |
| (d)(vii) |
| (d)(viii) |
C-2
| (d)(ix) |
| (d)(x) |
| (d)(xi) |
| (d)(xii) |
| (d)(xiii) |
| (d)(xiv) |
| (d)(xv) |
| (d)(xvi) |
| (d)(xvii) |
| (d)(xviii) |
| (d)(xix) |
| (d)(xx) |
| (d)(xxi) |
| (d)(xxii) |
| (e) |
| (e)(i) |
| (f) |
| (g) |
| (h) |
| (d) | Contracts. (Including Riders and Endorsements) |
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |
| (g) |
| (h) |
| (i) |
| (j) |
| (k) |
| (l) |
| (m) |
| (n) |
| (o) |
| (p) |
| (q) |
| (r) |
| (s) |
C-3
| (t) |
| (u) |
| (v) |
| (w) |
| (e) | Applications. |
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |
| (g) |
| (h) |
| (i) |
| (f) | Insurance Company’s Certificate of Incorporation And By-Laws. |
| (a) |
| (a)(i) |
| (b) |
| (b)(i) |
| (b)(ii) |
| (g) | Reinsurance Contracts. |
| (a) |
| (h) | Participation Agreements. |
| (a) |
| (a)(i) |
| (a)(ii) |
| (a)(iii) |
| (a)(iv) |
| (a)(v) |
| (a)(vi) |
| (a)(vii) |
| (a)(viii) |
| (a)(ix) |
| (a)(x) |
| (a)(xi) |
| (a)(xii) |
| (a)(xiii) |
| (a)(xiv) |
| (a)(xv) |
| (a)(xvi) |
| (a)(b)(i) |
| (a)(b)(ii) |
| (a)(b)(iii) |
| (a)(b)(iv) |
| (a)(b)(v) |
| (a)(b)(vi) |
| (a)(b)(vii) |
| (a)(b)(viii) |
| (a)(b)(ix) |
| (a)(b)(x) |
| (a)(b)(xi) |
| (a)(b)(xii) |
| (a)(b)(xiii) |
| (a)(b)(xiv) |
| (a)(b)(xv) |
| (a)(b)(xvi) |
| (a)(b)(xvii) |
| (a)(b)(xviii) |
| (a)(b)(xix) |
| (a)(b)(xx) |
| (a)(b)(xxi) |
| (a)(b)(xxii) |
| (a)(b)((xxiii) |
| (b) |
| (b)(i) |
| (b)(ii) |
| (b)(iii) |
| (b)(iv) |
| (b)(v) |
| (c) |
| (c)(i) |
| (d) |
| (d)(i) |
| (d)(ii) |
| (d)(iii) |
| (e) |
| (e)(i) |
| (e)(ii) |
| (f) |
C-4
| (g) |
| (g)(i) |
| (g)(ii) |
| (g)(iii) |
| (g)(iv) |
| (g)(v) |
| (g)(vi) |
| (g)(vii) |
| (g)(viii) |
| (g)(ix) |
| (g)(x) |
| (h) |
| (h)(i) |
| (i) |
| (i)(i) |
| (i)(ii) |
| (i)(iii) |
| (j) |
| (j)(i) |
| (k) |
| (l) |
| (l)(i) |
| (l)(ii) |
| (l)(iii) |
| (l)(iv) |
| (m) |
| (m)(i) |
| (m)(ii) |
| (m)(iii) |
| (m)(iv) |
| (m)(v) |
| (m)(vi) |
| (m)(vii) |
| (i) | Administrative Contracts. |
| (j) | Other Material Contracts. Not applicable. |
| (k) | Legal Opinion. |
| (l) | Other Opinions. |
| (a) |
| (b) | Consent of Independent Registered Public Accounting Firm, filed herewith. |
| (m) | Omitted Financial Statements. Not applicable. |
| (n) | Initial Capital Agreements. Not applicable. |
| (o) |
| (p) |
| (q) | Letter Regarding Change in Certifying Accountant. Not applicable. |
| (r) |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
C-5
| Item 28. | Directors and Officers of the Insurance Company. |
Set forth below is information regarding the directors and principal officers of the Insurance Company. The Insurance Company’s address is 1345 Avenue of the Americas, New York, New York 10105. The business address of the persons whose names are preceded by an asterisk is that of the Insurance Company.
| NAME AND PRINCIPAL BUSINESS ADDRESS |
POSITIONS AND OFFICES WITH THE INSURANCE COMPANY | |
| DIRECTORS | ||
| Douglas A. Dachille | Director | |
| Legacy Liability Solutions, LLC | ||
| 161 N. Clark Street | ||
| Chicago, IL 60602 | ||
| Francis Hondal | Director | |
| 10050 W. Suburban Drive | ||
| Pinecrest, FL 33156 | ||
| Arlene Isaacs-Lowe | Director | |
| 1830 South Ocean Drive, #1411 | ||
| Hallandale, FL 33009 | ||
| Daniel G. Kaye | Director | |
| 767 Quail Run | ||
| Inverness, IL 60067 | ||
| Joan Lamm-Tennant | Director | |
| 135 Ridge Common | ||
| Fairfield, CT 06824 | ||
| Craig MacKay | Director | |
| England & Company | ||
| 1133 Avenue of the Americas | ||
| Suite 2719 | ||
| New York, NY 10036 | ||
| Bertram L. Scott | Director | |
| 3601 Hampton Manor Drive | ||
| Charlotte, NC 28226 | ||
| George Stansfield | Director | |
| AXA | ||
| 25, Avenue Matignon | ||
| 75008 Paris, France | ||
| Charles G.T. Stonehill | Director | |
| Founding Partner | ||
| Green & Blue Advisors | ||
| 525 Park Avenue, 8D | ||
| New York, New York 10065 | ||
| OFFICER-DIRECTOR | ||
| *Mark Pearson | Director and Chief Executive Officer | |
| OTHER OFFICERS | ||
| *Nicholas B. Lane | President | |
| *José Ramón González | Chief Legal Officer and Secretary | |
| *Jeffrey J. Hurd | Chief Operating Officer | |
C-6
| *Robin M. Raju | Chief Financial Officer | |
| *Michael B. Healy | Chief Information Officer | |
| *Nicholas Huth | Chief Compliance Officer | |
| *William Eckert | Chief Accounting Officer | |
| *Darryl Gibbs | Chief Diversity Officer | |
| *David W. Karr | Signatory Officer | |
| *Erik Bass | Chief Strategy Officer and Signatory Officer | |
| *Mary Jean Bonadonna | Signatory Officer | |
| *Nicholas Chan | Deputy Treasurer | |
| *Eric Colby | Signatory Officer | |
| *Glen Gardner | Chief Investment Officer | |
| *Kenneth Kozlowski | Signatory Officer | |
| *Carol Macaluso | Signatory Officer | |
| *James Mellin | Signatory Officer | |
| *Hillary Menard | Signatory Officer | |
| *Kurt Meyers | Deputy General Counsel and Signatory Officer | |
| *Maryanne (Masha) Mousserie | Signatory Officer | |
| *Prabha (“Mary”) Ng | Chief Information Security Officer | |
| *Antonio Di Caro | Signatory Officer | |
| *Shelby Hollister-Share | Signatory Officer | |
C-7
| *Manuel Prendes | Signatory Officer | |
| *Stephen Scanlon | Signatory Officer | |
| *Samuel Schwartz | Signatory Officer | |
| *Stephanie Shields | Signatory Officer | |
| *Joseph M. Spagnuolo | Signatory Officer | |
| *Qi Ning (“Peter”) Tian | Treasurer | |
| *Gina Tyler | Chief Communications Officer | |
| *Constance Weaver | Chief Marketing Officer | |
| *Xu (“Vincent”) Xuan | Chief Actuary | |
| *Yun (“Julia”) Zhang | Chief Risk Officer | |
C-8
| Item 29. | Persons Controlled by or Under Common Control with the Insurance Company or the Registered Separate Account. |
Separate Account A of Equitable Financial Life Insurance Company (the “Separate Account”) is a separate account of Equitable Financial Life Insurance Company. Equitable Financial Life Insurance Company, a New York stock life insurance company, is an indirect wholly owned subsidiary of Equitable Holdings, Inc. (the “Holding Company”).
Set forth below is the subsidiary chart for the Holding Company:
C-9
| Item 30. | Indemnification |
| (a) | Indemnification of Directors and Officers |
The By-Laws of Equitable Financial Life Insurance Company (“Equitable Financial”) provide, in Article VII, as follows:
| 7.4 | Indemnification of Directors, Officers and Employees. |
| (a) | To the extent permitted by the law of the State of New York and subject to all applicable requirements thereof: |
| (i) | any person made or threatened to be made a party to any action or proceeding, whether civil or criminal, by reason of the fact that he or she, or his or her testator or intestate, is or was a director, officer or employee of the Company shall be indemnified by the Company; |
| (ii) | any person made or threatened to be made a party to any action or proceeding, whether civil or criminal, by reason of the fact that he or she, or his or her testator or intestate serves or served any other organization in any capacity at the request of the Company may be indemnified by the Company; and |
| (iii) | the related expenses of any such person in any of said categories may be advanced by the Company. |
| (b) | To the extent permitted by the law of the State of New York, the Company may provide for further indemnification or advancement of expenses by resolution of shareholders of the Company or the Board of Directors, by amendment of these By-Laws, or by agreement. (Business Corporation Law ss. 721-726; Insurance Law ss. 1216) |
The directors and officers of the Company are insured under policies issued by X.L. Insurance Company, Arch Insurance Company, Endurance Specialty Insurance Company, U.S. Specialty Insurance, ACE, Chubb Insurance Company, AXIS Insurance Company, Zurich Insurance Company, AWAC (Allied World Assurance Company Ltd.), Aspen Bermuda XS, CNA, AIG, Nationwide, Berkley, Berkshire, SOMPO, Chubb, Markel, Ascot, Bowhead, and Westfield. The annual limit on such policies is $300 million, and the policies insure the officers and directors against certain liabilities arising out of their conduct in such capacities.
| (b) | Indemnification of Principal Underwriters |
To the extent permitted by law of the State of New York and subject to all applicable requirements thereof, Equitable Distributors, LLC and Equitable Advisors, LLC have undertaken to indemnify each of its directors and officers who is made or threatened to be made a party to any action or proceeding, whether civil or criminal, by reason of the fact the director or officer, or his or her testator or intestate, is or was a director or officer of Equitable Advisors, LLC or Equitable Distribution, LLC.
| (c) | Undertaking |
Insofar as indemnification for liability arising under the Securities Act of 1933 (“Act”) may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
C-10
ITEM 31. PRINCIPAL UNDERWRITERS
| (a) | Equitable Advisors, LLC and Equitable Distributors, LLC are the principal underwriters for: |
| (i) | Separate Account No. 49, Separate Account No. 70, Separate Account A, Separate Account FP, Separate Account I and Separate Account No. 45 of Equitable Financial |
| (ii) | Separate Account No. 49B of Equitable Colorado |
| (iii) | EQ Advisors Trust |
| (iv) | Variable Account AA, Equitable America Variable Account A, Equitable America Variable Account K, Equitable America Variable Account L, and Equitable America Variable Account 70A. |
| (b) | Equitable Advisors is the principal underwriter of Equitable Financial’s Separate Account No. 301. |
| (c) | Set forth below is certain information regarding the directors and principal officers of Equitable Advisors, LLC and Equitable Distributors, LLC: |
EQUITABLE ADVISORS, LLC
| NAME AND PRINCIPAL |
POSITIONS AND OFFICES WITH UNDERWRITER | |
| *David Karr | Director, Chairman of the Board and Chief Executive Officer | |
| *Nicholas B. Lane | Director | |
| *Frank Massa | Director and President | |
| *Yun (“Julia”) Zhang | Director | |
| *Ralph E. Browning, II | Chief Privacy Officer | |
| *Mary Jean Bonadonna | Chief Risk Officer | |
| *Patricia Boylan | Broker Dealer Chief Compliance Officer | |
| *Nia Dalley | Vice President and Chief Conflicts Officer | |
| *Brett Esselburn | Vice President, Investment Sales and Financial Planning | |
| *Gina Jones | Vice President and Financial Crime Officer | |
| *Tracy Zimmerer | Vice President, Principal Operations Officer | |
| *Sean Donovan | Assistant Vice President | |
| *Alan Gradzki | Assistant Vice President | |
| *Janie Smith | Assistant Vice President | |
| *James Mellin | Chief Sales Officer | |
| *Candace Scappator | Assistant Vice President, Controller and Principal Financial Officer | |
| *Prabha (“Mary”) Ng | Chief Information Security Officer | |
| *Alfred Ayensu-Ghartey | Vice President | |
| *Joshua Katz | Vice President | |
| *Dustin Long | Vice President | |
| *Christopher LaRussa | Investment Advisor Chief Compliance Officer | |
| *Christian Cannon | Vice President and General Counsel | |
| Paul Scott Peterson | Vice President, Assistant Treasurer and Signatory Officer | |
| *Samuel Schwartz | Vice President | |
C-11
| *Dennis Sullivan | Vice President | |
| *Peter Tian | Senior Vice President, Treasurer and Signatory Officer | |
| *Constance (Connie) Weaver | Vice President | |
| *Michael Brudoley | Secretary | |
| *Christine Medy | Assistant Secretary | |
| *Francesca Divone | Assistant Secretary | |
EQUITABLE DISTRIBUTORS, LLC
| NAME AND PRINCIPAL |
POSITIONS AND OFFICES WITH UNDERWRITER | |
| *Nicholas B. Lane | Director, Chairman of the Board, President and Chief Executive Officer | |
| *Jim Kais | Director and Head of Group Retirement | |
| *Jason Brown | Deputy Chief Compliance Officer | |
| *Ursula Carty | Head of Commercial Line Marketing | |
| *Amy Feintuch | Head of Independent Relationships- Financial Protection | |
| *Steve Junge | National Sales Manager – 1290 Funds | |
| *James O’Connor | Head of Business Development and Key Accounts Group Retirement | |
| *David Kahal | Signatory Officer | |
| *Fred Makonnen | Signatory Officer | |
| *Arielle D’ Auguste | Signatory Officer and General Counsel | |
| *Alfred D’Urso | Signatory Officer and Chief Compliance Officer | |
| *Candace Scappator | Signatory Officer, Chief Financial Officer, Principal Financial Officer and Principal Operations Officer | |
| *Gina Jones | Signatory Officer and Financial Crime Officer | |
| *Yun (“Julia”) Zhang | Signatory Officer and Chief Risk Officer | |
| *Francesca Divone | Secretary | |
| *Stephen Scanlon | Director, Head of Individual Retirement and Signatory Officer | |
C-12
| *Prabha (“Mary”) Ng | Signatory Officer and Chief Information Security Officer | |
| *Michael Brudoley | Assistant Secretary | |
| *Christine Medy | Assistant Secretary | |
* Principal Business Address:
1345 Avenue of the Americas
NY, NY 10105
C-13
(d)
| Name of Principal Underwriter |
Net Underwriting Discounts |
Compensation on Redemption |
Brokerage Commission |
Other Compensation |
||||||||||
| Equitable Advisors, LLC |
N/A | $ | 0 | $ | 0 | $ | 0 | |||||||
| Equitable Distributors, LLC |
N/A | $ | 0 | $ | 0 | $ | 0 | |||||||
ITEM 31A. Information about Contracts with Index-Linked Options and Fixed Options Subject to a Contract Adjustment.
| (a) | For any Contract with Index-Linked Options and/or Fixed Options subject to a Contract Adjustment offered through this registration statement, provide the information required by the following table as of December 31 of the prior calendar year. |
| Name of the Contract |
Number of Contracts outstanding |
Total value attributable to the Index- Linked Option and/or Fixed Option subject to a Contract Adjustment |
Number of Contracts sold during the prior calendar year |
Gross premiums received during the prior calendar year |
Amount of Contract value redemmed during the prior year |
Combination Contract (Yes/No) |
||||||||||||||||||
| EQUI-VEST (Series 201) |
516,760 | $ | 808,699,454 | 23,004 | $ | 1,654,139,946 | $ | 1,209,640,184 | Yes | |||||||||||||||
| (b) | See Exhibit (27)(r) Historical Current Limits on Index Gains. |
C-14
| Item 32. | Location of Accounts and Records |
This information is omitted as it is provided in Registered Separate Account’s most recent report on Form N-CEN.
| Item 33. | Management Services |
Not applicable.
| Item 34. | Fee Representaion and Undertakings |
| (a) | The Insurance Company represents, with respect to the variable investment options, that the fees and charges deducted under the Contracts described in this Registration Statement, in the aggregate, are reasonable in relation to the services rendered, the expenses expected to be incurred, and the risks assumed by the Insurance Company under the respective Contracts. |
The Registered Separate Account hereby represents that it is relying on the November 28, 1988 no action letter (Ref. No. IP-6-88) relating to variable annuity contracts offered as funding vehicles for retirement plans meeting the requirements of Section 403(b) of the Internal Revenue Code. Registered Separate Account further represents that it will comply with the provisions of paragraphs (1)-(4) of that letter.
| (b) | With regard to Index-Linked Options and/or Fixed Options subject to a Contract Adjustment, the Insurance Company hereby undertakes: |
| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to the registration statement to include any prospectus required by section 10(a)(3) of the Securities Act; and |
| (2) | That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
The Insurance Company hereby further represents that it is relying upon Rule 6c-7 of the Investment Company Act of 1940 (the “1940 Act”) in claiming an exemption from certain provisions of Sections 22(e) and 27 of the 1940 Act for registered separate accounts offering variable annuity contracts to participants in the Texas Optional Retirement program. Further, Equitable Financial has or will comply with Rule 6c-7(a)-(d) of the 1940 Act with respect to Texas Optional Retirement Program participants.
C-15
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets all of the requirements for effectiveness of this registration statement under rule 485(b) under the Securities Act and has duly caused this registration statement to be signed on its behalf by the undersigned, duly authorized, in the City and State of New York, on this 22nd day of August, 2025.
| Separate Account A | ||
| (Registered Separate Account) | ||
| By: | /s/ Alfred Ayensu-Ghartey | |
| Alfred Ayensu-Ghartey | ||
| Vice President and Associate General Counsel | ||
| Equitable Financial Life Insurance Company | ||
| (Insurance Company) | ||
| By: | /s/ Alfred Ayensu-Ghartey | |
| Alfred Ayensu-Ghartey | ||
| Vice President and Associate General Counsel | ||
SIGNATURES
As required by the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated:
| PRINCIPAL EXECUTIVE OFFICER: | ||
| *Mark Pearson | Chief Executive Officer and Director | |
| PRINCIPAL FINANCIAL OFFICER: | ||
| *Robin Raju | Chief Financial Officer | |
| PRINCIPAL ACCOUNTING OFFICER: | ||
| *William Eckert | Chief Accounting Officer | |
| *DIRECTORS: | ||||||
| Francis Hondal Joan Lamm-Tennant Daniel G. Kaye Arlene Issacs-Lowe Mark Pearson |
Bertram Scott George Stansfield Charles G.T. Stonehill Craig MacKay Douglas A. Dachille |
|||||
| *By: | /s/ Alfred Ayensu-Ghartey | |
| Alfred Ayensu-Ghartey | ||
| Attorney-in-Fact | ||
| August 22, 2025 |
ATTACHMENTS / EXHIBITS
CONSENT OF PRICEWATERHOUSECOOPERS LLP
EQUITABLE HOLDINGS, INC. - SUBSIDIARY ORGANIZATION CHART: Q1-2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ethereum Price Prediction: ETH Faces $2,800 Resistance as AlphaPepe Builds a $2.87M Presale Around AI Trading
- Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer
- Best Crypto Presale: 5 Signs Why AlphaPepe Could Be More Than the Next Meme Coin Pump
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share